title: Neuro-oncology: anaplastic oligodendrogliomas-value of early chemotherapy.
authors.forename: François
authors.initials: F
authors.lastname: Ducray
authors.forename: Ahmed
authors.initials: A
authors.lastname: Idbaih
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality / Q000532:radiotherapy; D017024:Chemotherapy, Adjuvant; D002872:Chromosome Deletion; D002878:Chromosomes, Human, Pair 1 / Q000235:genetics; D002888:Chromosomes, Human, Pair 19 / Q000235:genetics; D002945:Cisplatin / Q000008:administration & dosage; D017326:Clinical Trials, Phase III as Topic; D003131:Combined Modality Therapy; D004265:DNA Helicases / Q000235:genetics; D061345:Early Medical Intervention; D005500:Follow-Up Studies; D006801:Humans; D007521:Isocitrate Dehydrogenase / Q000235:genetics; D009687:Nuclear Proteins / Q000235:genetics; D009837:Oligodendroglioma / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality / Q000532:radiotherapy; D011379:Prognosis; D015996:Survival Rate; D043823:Taxoids / Q000008:administration & dosage; D016159:Tumor Suppressor Protein p53 / Q000235:genetics; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000075924:X-linked Nuclear Protein
chemical_list: D009687:Nuclear Proteins; C495901:TP53 protein, human; D043823:Taxoids; D016159:Tumor Suppressor Protein p53; D014747:Vinblastine; D007521:Isocitrate Dehydrogenase; D004265:DNA Helicases; C092332:ATRX protein, human; D000075924:X-linked Nuclear Protein; D002945:Cisplatin